Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways

Journal of Neuroscience Research

Volumn 82, Issue 6, 2005, Pages 839-850

  Cheeran, Maxim C J ^a   Hu, Shuxian ^a   Ni, Hsiao T ^b   Sheng, Wen ^a   Palmquist, Joseph M ^a   Peterson, Phillip K ^a   Lokensgard, James R ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b R and D Systems Inc   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

C EBP ; Differentiation; Human cytomegalovirus; MIEP; NPC

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CCAAT ENHANCER BINDING PROTEIN BETA; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; PLATELET DERIVED GROWTH FACTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FETUS; GENETIC TRANSFECTION; GLIA; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; VIRUS REPLICATION;

ANTIGENS, CD; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOMEGALOVIRUS; FETUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; L-LACTATE DEHYDROGENASE; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PEPTIDES; PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFECTION;

EID: 28544433757     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20682     Document Type: Article

References (41)

1. Barber SA, Herbst DS, Bullock BT, Gama L, Clements JE. 2004. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol 10(Suppl 1):15-20.
2. Brustle O, Spiro AC, Karram K, Choudhary K, Okabe S, McKay RD. 1997. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci U S A 94:14809-14814.
3. Carpenter MK, Cui X, Hu ZY, Jackson J, Sherman S, Seiger A, Wahlberg LU. 1999. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 158:265-278.
4. Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. 2001. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172:383-397.
5. Cheeran MC, Hu S, Gekker G, Lokensgard JR. 2000. Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes. J Immunol 164:926-933.
6. Demmler GJ. 1991. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13:315-329.
7. Descombes P, Schibler U. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579.
8. Dittmer D, Mocarski ES. 1997. Human cytomegalovirus infection inhibits G1/S transition. J Virol 71:1629-1634.
9. Ferguson KL, Slack RS. 2003. Growth factors: can they promote neurogenesis? Trends Neurosci 26:283-285.
10. Gage FH. 2000. Mammalian neural stem cells. Science 287:1433-1438.
11. Gage FH, Ray J, Fisher LJ. 1995. Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 18:159-192.
12. Greaves RF, Mocarski ES. 1998. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus iel mutant. J Virol 72:366-379.
13. Ho WZ, Song L, Douglas SD. 1991. Human cytomegalovirus infection and trans-activation of HIV-1 LTR in human brain-derived cells. J Acquir Immune Defic Syndr 4:1098-1106.
14. Honda Y, Rogers L, Nakata K, Zhao BY, Pine R, Nakai Y, Kurosu K, Rom WN, Weiden M. 1998. Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)beta,repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 188:1255-1265.
15. Jault FM, Jault JM, Ruchti F, Fortunato EA, Clark C, Corbeil J, Richman DD, Spector DH. 1995. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 69:6697-6704.
16. Johe KK, Hazel TG, Muller T, Dugich-Djordjevic MM, McKay RD. 1996. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev 10:3129-3140.
17. Kawasaki H, Kosugi I, Arai Y, Tsutsui Y. 2002. The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. Lab Invest 82:1347-1358.
18. Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y. 2000. Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab Invest 80:1373-1383.
19. Lekstrom-Himes J, Xanthopoulos KG. 1998. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273:28545-28548.
20. Li RY, Tsutsui Y. 2000. Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology 62:79-85.
21. Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK. 1999. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 2:91-101.
22. Lu M, Shenk T. 1996. Human cytomegalovirus infection inhibits cell cycle progression at multiple points,including the transition from G1 to S. J Virol 70:8850-8857.
23. McCarthy M, Wood C, Fedoseyeva L, Whittemore SR. 1995. Media components influence viral gene expression assays in human fetal astrocyte cultures. J Neurovirol 1:275-285.
24. McCarthy M, Auger D, Whittemore SR. 2000. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J Hum Virol 3:215-228.
25. McKay R. 2000. Stem cells and the cellular organization of the brain. J Neurosci Res 59:298-300.
26. Menard C, Hein P, Paquin A, Savelson A, Yang XM, Lederfein D, Barnabe-Heider F, Mir AA, Sterneck E, Peterson AC, Johnson PF, Vinson C, Miller FD. 2002. An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36:597-610.
27. Ni H-T, Hu S, Sheng WS, Olson JM, Cheeran MC-J, Chan ASH, Lokensgard JR, Peterson PK. 2004. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res 152:159-169.
28. Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G 2nd, Jiang L, KangJ, Nedergaard M, Goldman SA. 2003. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9:439-447.
29. Ossipow V, Descombes P, Schibler U. 1993. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci U S A 90:8219-8223.
30. Perlman JM, Argyle C. 1992. Lethal cytomegalovirus infection in pre-term infants: clinical, radiological, and neuropathological findings. Ann Neurol 31:64-68.
31. Prosch S, Heine AK, Volk HD, Kruger DH. 2001. CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE 1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J Biol Chem 276:40712-40720.
32. Salvant BS, Fortunato EA, Spector DH. 1998. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 72:3729-3741.
33. Shinmura Y, Aiba-Masago S, Kosugi I, Li RY, Baba S, Tsutsui Y. 1997. Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Am J Pathol 151:1331-1340.
34. Spaete RR, Mocarski ES. 1987. Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A 84:7213-7217.
35. Spiller OB, Borysiewicz LK, Morgan BP. 1997. Development of a model for cytomegalovirus infection of oligodenrocytes. J Gen Virol 78:3349-3356.
36. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. 1986. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
37. Temple S. 2001. The development of neural stem cells. Nature 414:112-117.
38. Tsai RY, McKay RD. 2000. CeU contact regulates fate choice by cortical stem cells. J Neurosci 20:3725-3735.
39. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL. 2000. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97:14720-14725.
40. van Den Pol AN, Mocarski E, Saederup N, Vieira J, Meier TJ. 1999. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci 19:10948-10965.
41. Weiden M, Tanaka N, Qiao Y, Zhao BY, Honda Y, Nakata K, Canova A, Levy DE, Rom WN, Pine R. 2000. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 165:2028-2039.